QUALITY-OF-LIFE MEASURES IN CANCER-CHEMOTHERAPY - METHODOLOGY AND IMPLICATIONS

被引：15

作者：

GANZ, PA

机构：

[1] Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, UCLA Schools of Medicine and Public Health, Los Angeles, California, 90024, 1100 Glendon Avenue

来源：

PHARMACOECONOMICS | 1994年 / 5卷 / 05期

关键词：

D O I：

10.2165/00019053-199405050-00004

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

Quality of life has been an implied outcome of medical care since ancient times, yet only recently have tools become available to measure quality of life in a systematic fashion. Cancer is one of the chronic diseases where quality of life outcomes have been particularly salient. Currently, there are a wide variety of generic and cancer-specific instruments that are being used to evaluate the impact of cancer chemotherapy on the patient's quality of life. Most of these instruments rely on patient self-report rather than expert evaluation. The addition of quality-of-life (QOL) assessment to pharmacological investigations of cancer chemotherapy may enhance evaluation of clinical outcomes, as well as identify unsuspected drug toxicities. Clinicians, researchers and pharmaceutical companies are more frequently incorporating these measures into the design of cancer treatment protocols. Data on the performance of these tools should become more widely available in the near future, leading to refinements in the selection and use of specific instruments for different purposes.

引用

页码：376 / 388

页数：13

共 84 条

[1]

Aaronson N.K., Quality of life: what is it? How should it be measured?, Oncology, 2, pp. 69-74, (1988)

[2]

Aaronson N.K., Acquadro C., Alonso J., Et al., International Quality of Life Assessment (IQOLA) Project, Quality of Life Research, 1, pp. 349-351, (1992)

[3]

Aaronson N.K., Ahmedzai S., Bergman B., Et al., The European Organization for Research and Treatment of Cancer quality of lifeQC30: a quality-of-life instrument for use in international clinical trials in oncology, Journal of the National Cancer Institute, 85, pp. 365-376, (1993)

[4]

Aaronson N.K., Bullinger M., Ahmedzai S., A modular approach to quality-of-life assessment in cancer clinical trials, Recent Results in Cancer Research, 111, pp. 231-249, (1988)

[5]

Andrews F.M., Withey S.B., Social indicators of well being: Americans’ perception of life quality, (1976)

[6]

Bergner M., Bobbin R.A., Carter W.B., Gilson B.S., The Sickness Impact Profile. Development and final revision of a health status measure, Medical Care, 19, pp. 787-806, (1981)

[7]

Bergner M., Bobbin R.A., Pollard W.E., Sickness Impact Profile. Validation of a health status measure, Medical Care, 14, pp. 57-61, (1976)

[8]

Breslow L., A quantitative approach to the World Health Organization definition of health: physical, mental and social well-being, International Journal of Epidemiology, 1, pp. 347-355, (1972)

[9]

Brook R.H., Ware J.E., Davies-Avery A., Et al., Overview of adult health status measures fielded in RAND’s Health Insurance Study, Medical Care, 17, pp. 1-131, (1979)

[10]

Campbell A., Subjective measures of well-being, American Psychologist, 31, pp. 117-124, (1974)

← 1 2 3 4 5 6 7 8 9 →